Chairs: Dr. Elena Verdu, McMaster University, Canada

This session highlights cutting-edge presentations by early career investigators on the emerging role of microbial proteases and microbial dietary protein metabolism, in driving inflammation in inflammatory bowel disease (IBD). New evidence on the physiological role for cell-gut microbiota interactions in orchestrating the spatial organization of mucosa-associated microbiota in the colon will be presented.

The emerging role of microbial proteolytic activity in inflammatory bowel disease
Heather Galipeau, Canada

Thrombin tension at host-microbiota interface: A role in Crohn's disease?
Jean-Paul Motta, France

Microbial antigen metabolism in adverse reactions to foods and intestinal inflammation
Alberto Caminero, Canada

Neutrophils: From IBD to the gut microbiota
Camille Danne, France